Nicox signs agreement for NCX 4251 in China with Ocumension Therapeutics for up to €12 million in milestones plus royalties

July 2, 2019

EN_Ocumension deal NCX 4251_PR_July 2.2019

← Back to blog page

Cookies

By continuing to use this website, you agree to our Cookie Policy.